Evoked otoacoustic emissions and electrocochleography in a patient with multiple sclerosis

Audiovestibular Evolution in a Patient with Multiple Sclerosis

Multiple sclerosis is characterized by the presence of multiple plaques within the central nervous system, manifesting as remission and exacerbation of neurologic dysfunction over variable time courses. We present the case of a 20-year-old woman. Before treatment, her auditory brain stem response (ABR) test revealed bilateral prolongation. A caloric test showed canal paresis of the right ear and a normal response on the left. A vestibular evoked myogenic potential (VEMP) test displayed an absent response in the right ear and a delayed response in the left. A magnetic resonance imaging (MRI) scan demonstrated multiple diffuse high signal lesions in the hemispheres, brain stem, and cerebellum. Six months after treatment, the demyelinating plaques were shown to have resolved spontaneously on MRI. Recovery of caloric responses was anticipated. Bilateral prolongation of ABRs remained, but the VEMP test disclosed a normal response in the right ear and a delayed response in the left. Accordingly, in addition to MRI, caloric tests and ABR and VEMP tests are useful in monitoring the evolution of audiovestibular function in patients with multiple sclerosis.

Auditory Efferent Function Is Affected in Multiple Sclerosis

OBJECTIVE

This study evaluated efferent medial olivocochlear (MOC) function in patients with multiple sclerosis (MS). Various afferent auditory abnormalities have been described in MS, but there is a paucity of data on efferent function. The brain stem is a site of predilection for MS plaques and the efferent MOC pathway may be affected at this level.

METHODS

The study included 30 patients who had normal hearing. According to MRI findings, they were divided into two groups: those with an identifiable brain stem lesion (n = 10) and those with MS lesions in other parts of the central nervous system but without demonstrable MS plaques in the brain stem (n = 20). MOC function was evaluated by the olivocochlear suppression test, using transient evoked otoacoustic emissions. All subjects underwent standard auditory tests, including pure-tone audiometry and recording of auditory brain stem evoked responses. Twenty-two healthy subjects with normal hearing, matched for age and gender, served as a reference group for the auditory data.

RESULTS

The results showed that 66.6% of all patients had reduced MOC function, particularly those (90%) with identified lesions of the brain stem on MRI. Furthermore, abnormal MOC function was found in 55% patients without evidence of a brain stem lesion on MRI.

CONCLUSIONS

This study provides the evidence for a deficit of efferent auditory function in the majority of patients with MS. Taking into consideration the possible roles of the MOC system in processing of auditory information, abnormal MOC suppression in patients with MS may explain a variety of auditory presentations that are currently largely overlooked. This study also highlights the diagnostic value of the MOC suppression test as a site-of-lesion diagnostic test in MS and in identifying subtle brain stem lesions undetected by MRI, suggesting that subtle brain stem lesions may exist and that the MOC suppression test is sufficiently sensitive to detect them. Accordingly, the MOC suppression test may provide a tool for an early diagnosis of MS.

Physiological effects of auditory nerve myelinopathy in chinchillas

The goals were to study the physiological effects of auditory nerve myelinopathy in chinchillas and to test the hypothesis that myelin abnormalities could account for auditory neuropathy, a hearing disorder characterized by absent auditory brainstem responses (ABRs) with preserved outer hair cell function. Doxorubicin, a cytotoxic drug used as an experimental demyelinating agent, was injected into the auditory nerve bundle of 18 chinchillas; six other chinchillas were injected with vehicle alone. Cochlear microphonics, compound action potentials (CAPs), inferior colliculus evoked potentials (IC-EVPs), cubic distortion product otoacoustic emissions and ABRs were recorded before and up to 2 months after injection. Cochleograms showed no hair cell loss in any of the animals and measures of outer hair cell function were normal (cubic distortion product otoacoustic emissions) or enhanced (cochlear microphonics) after injection. ABR was present in animals with mild myelin damage (n = 10) and absent in animals with severe myelin damage that included the myelin surrounding spiral ganglion cell bodies and fibers in Rosenthal's canal (n = 8). Animals with mild damage had reduced response amplitudes at 1 day, followed by recovery of CAP and enhancement of the IC-EVP. In animals with severe damage, CAP and IC-EVP thresholds were elevated, amplitudes were reduced, and latencies were prolonged at 1 day and thereafter. CAPs deteriorated over time, whereas IC-EVPs partially recovered; latencies remained consistently prolonged despite changes in amplitudes. The results support auditory nerve myelinopathy as a possible pathomechanism of auditory neuropathy but indicate that myelinopathy must be severe before physiological measures are affected.

An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas

OBJECTIVES

To objectify the effects of retrocochlear disease on distortion-product otoacoustic emissions (DPOAEs) by developing a computer-based software strategy for classifying DPOAE patterns as cochlear or noncochlear and to evaluate the sensitivities of these techniques in a large series of patients with unilateral acoustic neuromas.

STUDY DESIGN

Development of a novel, software-based method of DPOAE analysis, which was evaluated with data obtained from a retrospective review of the results from audiometric tests performed in a series of patients.

METHODS

A computer-based software strategy was developed, using frequency-specific data from normal-hearing adults, for the purpose of distinguishing cochlear from noncochlear patterns of hearing loss, by determining the discrepancies between DPOAEs and behavioral audiometry. Preoperative pure-tone thresholds and DPOAEs from 97 patients with surgically confirmed acoustic neuroma were compared using an objective method and a standard, subjective technique that was considered to be the gold standard. The effects of bilateral hearing losses, such as noise-induced hearing loss and presbycusis, were accounted for during the analysis to isolate the effects of the tumors on hearing thresholds and DPOAEs.

RESULTS

Overall, 55 (57%) of the tumor ears were assigned to the cochlear group (i.e., DPOAEs consistent with hearing thresholds), 40 (41%) to the noncochlear group (i.e., DPOAEs inconsistent with hearing thresholds), and 2 (2%) to an indeterminate group, using the subjective technique for classifying DPOAEs. There was no significant difference in the categorization of the patients with acoustic neuroma when employing the objective strategy. The objective algorithm, when modified to maximize the number of noncochlear identifications, led to assignments of 36 (37%) to the cochlear, 57 (59%) to the noncochlear, and 4 (4%) to the indeterminate categories.

CONCLUSIONS

Subjective analysis of a large series patients with acoustic neuromas showed that the majority of ears with tumors demonstrated cochlear (57%), rather than non-cochlear (41%), patterns of DPOAEs. The computerized, software-based algorithm developed for differentiating cochlear from noncochlear patterns of DPOAEs in patients with retrocochlear disease had a maximum sensitivity of 59%. This value was significantly higher than that reported in previous studies.

Electrocochleographic study in patients with vestibular schwannomas and U-shaped audiograms

To determine the nature of sensorineural hearing loss in the middle-frequency range (U-shaped audiogram), we compared the differences in electrocochleographic findings for 15 ears with vestibular schwannomas and 10 ears without tumours. Short-tone bursts of 0.5, 1, 2, and 4 kHz were used to evoke cochlear microphonics (CM). Ears with tumours had normal or lower CM detection thresholds than ears without tumours. Input-output curves for 1-kHz frequency were normal in 10 ears with tumours and in 1 ear without tumours. These indicate that tumour ears have no or mild cochlear dysfunction. In addition, CM detection thresholds of ears with tumours were lower than audiometric thresholds, particularly at the 1- and 2-kHz region. These findings suggest that the loss seen by audiometry in ears with vestibular schwannomas was from a retrocochlear component.

A comparison of extratympanic versus transtympanic recordings in electrocochleography

Detection thresholds, amplitudes and input output curves of cochlear microphonics (CMs), and action potentials (APs) determined by extratympanic electrocochleography (ET ECochG) were compared with those determined by transtympanic (TT) ECochG in the same ears. Two groups were studied: 12 ears in 9 volunteers with normal hearing, and 6 ears in 6 subjects with sensorineural hearing loss. Short tone bursts with frequencies of 0.5, 1, 2 and 4 kHz were used as acoustic stimuli to evoke CMs, and a click was presented to measure the APs. In both groups, although the two approaches produced large differences in amplitudes, nearly identical values were obtained for the CM and AP detection thresholds. The CM and AP input-output curves obtained from mean amplitudes at each intensity in normally-hearing ears had similar slopes with the two approaches. These findings demonstrate the clinical usefulness of ET ECochG.

The effect of lidocaine on chronic tinnitus: a quantitative cerebral perfusion study

The cerebral perfusion of a 55-year-old female patient with chronic tinnitus was investigated quantitatively by single photon emission computed tomography (SPECT) with the xenon133 inhalation method. The first investigation was performed under standard conditions, the second during suppression of tinnitus with intravenous injection of lidocaine. As a reference a healthy volunteer was included under the same conditions. The global cortical perfusion was identical on both sides except for increased perfusion in the auditory cortex, especially on the right side when tinnitus lasted during the first measurement. The second investigation under treatment with lidocaine and during the tinnitus-free interval showed a decrease of the global cortical perfusion with a slightly higher value at the temporal cortex bilaterally. In comparison to the first investigation, a difference between right and left auditory cortex could no longer be demonstrated, and also the difference between regional and global perfusion decreased. A cerebral effect under treatment of tinnitus with lidocaine was shown by the quantitative measurement of brain perfusion. It is debatable whether this effect on cerebral activity results from the medication or as a reaction to the tinnitus-free interval.

Clinical interpretations of transient otoacoustic emissions

PURPOSE

The purpose of this study was to characterize the relation of different ordinal patterns of transient otoacoustic emissions (TEOAES) with respect to underlying otologic disorders and auditory status.

PATIENTS AND METHODS

The results of TEOAEs in 225 patients with various auditory disorders were investigated and compared with normative data established from 90 subjects of various ages. TEOAEs were categorized according to four patterns: (1) normal (general response level within 90% of normative data, (2) reduced amplitude (general response level was > or =2 dB peak sound pressure level (pSPL), but less than the mean -1.64 SD of the normative data), (3) abnormal morphology of frequency spectrum (general response level was within normal limits, but reduced at > or =2 individual octave frequencies between 1,000 and 5,000 Hz), and (4) total absence (response level <2 dB pSPL).

RESULTS

This study showed that the normal pattern of TEOAEs, in terms of response amplitude, varied with age. Our results further indicated that a reduced amplitude pattern of TEOAEs was noted in patients with a mild sensorineural hearing loss (SNHL), negative tympanometric pressure, a pressure-equalization tube, and Meniere's disease. TEOAEs provided good frequency-specific information for patients with a noise-induced hearing loss. All patients with ossicular chain abnormalities, more than moderate SNHL, and a middle ear mass or effusion had total absence of TEOAEs. Patients with acoustic neuroma and brainstem lesions presented a complex profile of TEOAEs. In the follow-up of auditory function in patients undergoing otologic surgery, different patterns of TEOAEs between the preoperative and postoperative recordings were evident, which correlated with the hearing thresholds and middle ear status. The abnormal findings of TEOAEs due to specific auditory diseases were discussed.

CONCLUSION

The interpretation of TEOAEs can be facilitated through an analysis of specific patterns and in combination with other audiologic tests.

A new electrode (HN-5) for CM measurement in extratympanic electrocochleography

A new electrode (HN-5) for measuring cochlear microphonics (CMs) in extratympanic (ET) electrocochleography (ECochG) has been developed. The HN-5 electrode consists of a silver wire 2 mm in diameter and 5.0 cm in length connected to a low noise cable. The HN-5 electrode showed low impedance and excellent frequency characteristics. Using the dummy ear, artefact contamination tests, such as electromagnetic induction and mechanical vibration, were performed with the HN-5 electrode and various other electrodes. In the HN-5 electrode, artifact contaminations were kept within acceptable noise levels, whereas in the smaller electrodes, the measurable artifact contaminations were larger. The CMs were measured from subjects with normal hearing. CM findings obtained using the HN-5 electrode did not differ from those obtained by transtympanic (TT) ECochG, apart from their amplitude. HN-5 overcame the major disadvantage of the ET ECochG and provided a very favourable signal-to-noise ratio, resulting in repeatable response signals averaged from the same relatively small number of samples as those of TT ECochG. This resulted in successful CM measurements of ET ECochG.

Cochlear microphonics recordable at the non-shielded bedside using a new tubal transducer

A new tubal transducer (NC-3) for measuring cochlear microphonics (CM) in extratympanic electrocochleography (ECochG) was developed by improving the common hearing aid earphone. Using a human forearm as a dummy ear, the artifact contamination generated from the NC-3 tubal transducer was tested and the possibility of measuring the CM at a non-shielded bedside was studied. An HN-5 electrode was fixed to a subject's forearm, and a sound stimulus of 90 dBnHL was delivered through the tube of the NC-3. When the earphone of the transducer was placed at a right-angle to the electrode on either a vertical or horizontal plane and the electrode was placed in direct contact with the tip of the tube, contamination from electromagnetic induction and CM-like mechanical vibration were prevented. Using the HN-5 electrode and NC-3, extratympanic ECochG-CM was recorded from normal-hearing subjects in both a shielded soundproof room and a non-shielded ordinary, quiet room. No differences were found between CMs measured in the two rooms. These results suggest that the NC-3 overcomes the shortcomings of a loudspeaker system and allows CM to be recorded accurately at non-shielded bedsides.